CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
CytomX Therapeutics appointed Alejandra Carvajal as Chief Legal Officer, bringing over two decades of legal experience in the biotechnology sector. Ms. Carvajal previously served as CLO at Mersana Therapeutics and Momenta Pharmaceuticals, helping navigate the sale of both companies to Day One Biopharmaceuticals and Johnson & Johnson, respectively.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.